Gabriel Novaes de Rezende Batistella

Gabriel Novaes de Rezende Batistella

Auto-generated profile, based on publicly available information

Gabriel Novaes de Rezende Batistella

Affiliation HCor–Research Institute, São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2016 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
PSPaulo Victor Sgobbi de Souza
Paulo Victor Sgobbi de Souza
Wladimir Bocca Vieira de Rezende PintoWladimir Bocca Vieira de Rezende Pinto
Wladimir Bocca Vieira de Rezende Pinto
GBGabriel Novaes de Rezende Batistella
Gabriel Novaes de Rezende Batistella
TBThiago Bortholin
Thiago Bortholin
AOAcary Souza Bulle Oliveira
Acary Souza Bulle Oliveira

1 September 2016 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
PSPaulo Victor Sgobbi de Souza
Paulo Victor Sgobbi de Souza
GBGabriel Novaes de Rezende Batistella
Gabriel Novaes de Rezende Batistella
VLValéria Cavalcante Lino
Valéria Cavalcante Lino
Wladimir Bocca Vieira de Rezende PintoWladimir Bocca Vieira de Rezende Pinto
Wladimir Bocca Vieira de Rezende Pinto
MAMarcelo Annes
Marcelo Annes
AOAcary Souza Bulle Oliveira
Acary Souza Bulle Oliveira
Neuromuscular junction disorders represent a wide group of neurological diseases characterized by weakness, fatigability and variable degrees of appendicular, ocular and bulbar musculature involvement. Its main group of disorders includes autoimmune conditions, such as autoimmune acquired myasthenia gravis and Lambert-Eaton syndrome. However, an important group of diseases include congenital myasthenic syndromes with a genetic and sometimes hereditary basis that resemble and mimick many of the classic myasthenia neurological manifestations, but also have different presentations, which makes them a complex clinical, therapeutic and diagnostic challenge for most clinicians. We conducted a wide review of congenital myasthenic syndromes in their clinical, genetic and therapeutic aspects.

1 January 2020 in World Neurosurgery
Verified
Journal Article
Closed access
Giovanni BoschettiGiovanni Boschetti
Giovanni Boschetti
ASAdrialdo Jose Santos
Adrialdo Jose Santos
KFKellen Paiva Fermon
Kellen Paiva Fermon
GHGustavo Lopes de Freitas Honório
Gustavo Lopes de Freitas Honório
GBGabriel Batistella
Gabriel Batistella
SMSuzana Maria Fleury Malheiros
Suzana Maria Fleury Malheiros

20 June 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VVViviane C. Veiga
Viviane C. Veiga
SPStela Verzinhasse Peres
Stela Verzinhasse Peres
TOThatiane L. V. D. P. Ostolin
Thatiane L. V. D. P. Ostolin
FMFlavia Regina Moraes
Flavia Regina Moraes
TBTalita Rantin Belucci
Talita Rantin Belucci
OGon behalf of the TROMBOGLIO Study Group
on behalf of the TROMBOGLIO Study Group
Purpose: Central nervous system (CNS) malignant neoplasms may lead to venous thromboembolism (VTE) and bleeding, which result in rehospitalization, morbidity and mortality. We aimed to assess the incidence of VTE and bleeding in this population. Methods: This systematic review and meta-analysis (PROSPERO CRD42023423949) were based on a standardized search of PubMed, Virtual Health Library and Cochrane (n = 1653) in July 2023. After duplicate removal, data screening and collection were conducted by independent reviewers. The combined rates and 95% confidence intervals for the incidence of VTE and bleeding were calculated using the random effects model with double arcsine transformation. Subgroup analyses were performed based on sex, age, income, and type of tumor. Heterogeneity was calculated using Cochran’s Q test and I2 statistics. Egger’s test and funnel graphs were used to assess publication bias. Results: Only 36 studies were included, mainly retrospective cohorts (n = 30, 83.3%) from North America (n = 20). Most studies included were published in high-income countries. The sample size of studies varied between 34 and 21,384 adult patients, mostly based on gliomas (n = 30,045). For overall malignant primary CNS neoplasm, the pooled incidence was 13.68% (95%CI 9.79; 18.79) and 11.60% (95%CI 6.16; 18.41) for VTE and bleeding, respectively. The subgroup with elderly people aged 60 or over had the highest incidence of VTE (32.27% - 95%CI 14.40;53.31). The studies presented few biases, being mostly high quality. Despite some variability among the studies, we observed consistent results by performing sensitivity analysis, which highlight the robustness of our findings. Conclusions: Our study showed variability in the pooled incidence for both overall events and subgroup analyses. It was highlighted that individuals over 60 years old or diagnosed with GBM had a higher pooled incidence of VTE among those with overall CNS malignancies. It is important to note that the results of this meta-analysis refer mainly to studies carried out in high-income countries. This highlights the need for additional research in Latin America, and low- and middle-income countries.

1 February 2021 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
GBGabriel Novaes de Rezende Batistella
Gabriel Novaes de Rezende Batistella
ASAdrialdo José Santos
Adrialdo José Santos
MNManoel Antonio de Paiva Neto
Manoel Antonio de Paiva Neto
RFRobson Ferrigno
Robson Ferrigno
VCVeridiana Pires de Camargo
Veridiana Pires de Camargo
MMMarcos Vinicius Calfat Maldaun
Marcos Vinicius Calfat Maldaun
Background: Cancer patients in general and glioblastoma patients, in particular, have an increased risk of developing complications from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and reaching a balance between the risk of exposure to infection and the clinical benefit of their treatment is ideal. The aggressive behavior of this group of tumors justifies the need for a multidisciplinary team to assist in clinical decisions during the current pandemic. Brazil is now ranked #2 in the number of cases and deaths from COVID-19 pandemic, and existing disparities in the treatment of neuro-oncology patients in Brazil will challenge the clinical and surgical decisions of this population, possibly affecting global survival. Objective: To search the literature about the management of glioblastomas during COVID-19 pandemic to guide surgical and clinical decisions in this population of patients in Brazil. Methods: We performed a systematic search on the PubMed electronic database targeting consensus statements concerning glioblastoma approaches during COVID-19 pandemic up to July 18, 2020. Results: When approaching glioblastoma during the COVID-19 pandemic, important parameters that help in the decision-making process are age, performance status, tumor molecular profile, and patient consent. Younger patients should follow the standard protocol after maximal safe resection, mainly those with MGMT methylated tumors. Aged and underperforming patients should be carefully evaluated, and probably a monotherapy scheme is to be considered. Centers are advised to engage in telemedicine and to elaborate means to reduce local infection. Conclusion: Approaching glioblastoma during the COVID-19 pandemic will be challenging worldwide, but particularly in Brazil, where a significant inequality of healthcare exists.

9 February 2016 in Neurology
Verified
Journal Article
Closed access
PDF file
PSPaulo Victor Sgobbi de Souza
Paulo Victor Sgobbi de Souza
GBGabriel Novaes de Rezende Batistella
Gabriel Novaes de Rezende Batistella
Wladimir Bocca Vieira de Rezende PintoWladimir Bocca Vieira de Rezende Pinto
Wladimir Bocca Vieira de Rezende Pinto
AOAcary Souza Bulle Oliveira
Acary Souza Bulle Oliveira